The Latest Cardiac and Vascular News
DANVERS, Mass., June 30, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced today the recent publication of a peer-reviewed retrospective study on hemodynamic support with the Impella 2.5® heart pump. The study analyzed patients with acute myocardial infarction complicated by cardiogenic shock […]
WASHINGTON, June 09, 2017 (GLOBE NEWSWIRE) — Nineteen patients who benefitted from treatment with Abiomed’s Impella heart pumps traveled to Washington, D.C. on June 8, 2017, to meet with elected officials and participate in a Congressional Briefing hosted by the MedTech Caucus, which supports the development of innovative technology. This […]
DANVERS, Mass., May 09, 2017 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support and recovery technologies, announced the debut of the 3rd Generation Impella CP heart pump at the Annual meeting of the Society for Cardiovascular and Angiography Interventions (SCAI 2017) in New Orleans, LA. […]
Abiomed Marks Grand Opening of Newly-Expanded Headquarters in Danvers, Massachusetts – Governor Baker joins heart recovery leader for grand opening of new manufacturing and training space that represents major investment in Massachusetts DANVERS, Mass., March 30, 2017 (GLOBE NEWSWIRE) — Massachusetts Governor Charlie Baker today joined Abiomed – a leading […]
DANVERS, Mass., March 09, 2017 (GLOBE NEWSWIRE) — A new study published in Circulation Research finds use of hemodynamic support with Impella® 2.5 heart pump during high-risk percutaneous coronary intervention (HRPCI) can reduce the risk of acute kidney injury (AKI) even when those patients had preexisting kidney disease1 and low […]
